HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

EXPO

Exponent, Inc. (NASDAQ)

Industrials — Engineering & Construction

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.

None 3 analysts
$59.94
+$1.18 (+2.01%)
Target: $81.67 (36.2%)
Sign in to add EXPO to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$2.91B
P/E Ratio (TTM)28.01
Forward P/E21.72
EPS (TTM)$2.14
Dividend Yield2.04%
Profit Margin19.76%
Revenue Growth10.50%
ROE27.94%
Debt/Equity23.95
Recommendation None
Analyst Target$81.67
Analysts3
Indexes NASDAQ

Technical Indicators

RSI (14)69.6
Beta0.73
SMA 20-
SMA 40-
52-Week High$81.95
52-Week Low$51.91
50-Day Avg$59.91
200-Day Avg$67.64
Avg Volume566.9K
Volume716.3K

Performance Analysis

BULLISH

EXPO shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 27% of its 52-week range.
+ RSI at 69.6 shows positive momentum.
~ Modest revenue growth of 10.5% year-over-year.
~ Wall Street consensus is "none" from 3 analysts.
+ Average analyst target of $81.67 implies 36.2% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:08 UTC

Back to Screener Export Report